diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
All participants will get an introduction to the TENSORTIP COG (MP) and one device will be individually assigned. This is followed by a week of calibration by the participants at home. All calibration
Sponsors
CNOGA Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy subjects verified by safety chemistry and blood count 2. Able to complete and understand informed consent form (by him/herself or by his/her guardian) 3. 18 years old and above 4. No constant treatment with medication 5. Safety biochemistry and blood count with exclusively values in normal range
Exclusion criteria
Exclusion criteria: 1. Severe life-threatening disease 2. Anatomical conditions that may hamper good contact between the device and the measured finger, at the discretion of the investigator 3. Pregnancy 4. Nursing mothers 5. Healthy volunteers with a hypersensitivity to any of the tested interferents 6. History of alcoholism (anamnestic exclusion)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Influence of different drugs and/or nutritional supplements on the result of the non-invasive glucose measuring CoG device measured weekly over 10-weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Impact of different drugs and/or nutritional supplements on the results of the invasive CoG device in comparison to the YSI reference method 2. Impact of different drugs and/or nutritional supplements on the results of the YSI device in comparison to a standard laboratory method. | — |
Countries
Germany
Outcome results
None listed